Hersteller/Inverkehrbringer: DOGenesis GmbH, Geschftsfhrer: Robert Franz, Mainzer Str
A commentary in the Journal of Managed Care & Specialty Pharmacy reports the incremental cost-effectiveness ratios at $66,355, $75,456 and $57,779 per quality-adjusted life-year, respectively, figures that place all three inside the range payers conventionally treat as reasonable value
Have a history of head injury , tumor , or seizure risk factors
% PDI activity was calculated from absorbance values at T =0 and 80 min
Vigor Compounding helps practices navigate these programs by working with licensed pharmacy partners and offering compliance-focused guidance
DISA provides information technology (IT) and communications support to the President, Vice President, Secretary of Defense, military services, combatant commands, and any individual or system contributing to the defense of the US